General Info
Location: 2420 Sand Hill Road
Country: Japan
Industries: biotech
Investment Regions: EU, NA
Investment Stages: pre-seed
Website: http://www.taihoventures.com/
corporate-vc
EU, NA
Want to start building warm intros with this investor?
🤖 AI Activity Report
Status: not-active
AI Reasoning: Searches found Taiho Ventures press releases in 2024 (e.g., expanded investment pool, April/January 2024) and portfolio listings but no evidence of any investments or announced investments in 2025. The most recent verifiable activity was in 2024 (press release about expanding pool and portfolio mentions). The last named portfolio/press activity referencing an investment is from 2024; the startup mentioned in related materials includes Arcus Biosciences (historical) and portfolio listings (e.g., Anavo Therapeutics). Using the cutoff, the last known investment activity was more than 12 months ago, so tag as not-active.
Here are the thresholds established for the different statuses:
Not Active – No known investments in the last 12 months.
Low Activity – Only known investments between the last 12 and 6 months.
Active – Known investments between the last 6 and 3 months.
Very Active – Known investments in the last 3 months.
Investor Contact
Team Members
Name
Role
Email
LinkedIn
Sakae …
President
Shinichi …
Investment Director
Seiji …
Investment Director
Takaaki …
Associate Investment Director
…
Warm Intros from Portfolio Companies
Investment Regions Map
loading map…
Similar Investors
Other similar investors:
Latest on X (Twitter)
Access all contact details of Taiho Ventures, LLC

Gain instant access to partner names, verified emails, LinkedIn profiles, and more—all in one place. Dive into their portfolio founders and their LinkedIn information, so you can quickly start your outreach and look for warm intros.
Add custom tags to your investor cards. Label them by investment stage, industry focus, interest level, or any other criteria you want to stay organized.
Trusted by Founders like You
Find your matching investors using AI
